EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Radiological Surveillance for Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1: A Longitudinal Cohort Study

Yetunde B Omotosho, Nayan U Vikram, Elizabeth C Wright, Venkata Dola, Wafa Abbas, Rana Tora, Lynn Bliss, Craig Cochran, Carl F Pieper, Prashant Chittiboina iD, Lee S Weinstein, William F Simonds iD und 2 weitere

The Journal of Clinical Endocrinology & Metabolism · 2026

DOI: 10.1210/clinem/dgaf704 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Yetunde B Omotosho und 13 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20814, USA. Hauptthemen laut MEDLINE: Pituitary Neoplasms, Multiple Endocrine Neoplasia Type 1, Adenoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Patients with multiple endocrine neoplasia type 1 (MEN1) are genetically predisposed to developing tumors of the parathyroid, pancreas, and anterior pituitary. While widespread genetic testing has increased early diagnoses, the value of radiological surveillance for pituitary adenomas in these patients remains unclear.

Objective

To investigate the impact of pituitary magnetic resonance imaging (MRI) findings on patient management in MEN1.

Design

Retrospective longitudinal cohort study.

Setting

NIH Clinical Center. Patients Genetically confirmed MEN1 evaluated between 1977 and September 2024. Measures Cumulative proportion and rate of intervention for nonfunctional adenomas.

Results

Three hundred twenty patients with a mean follow-up duration of 14 ± 12 years were identified. One hundred eighty-two out of 320 patients (57%) had pituitary adenomas, of whom 95/182 (52%) had nonfunctional adenomas. All patients with adenoma had biochemical evaluation at the time of pituitary MRI. There were 21/95 (22%) patients with nonfunctional adenomas that needed an intervention throughout their follow-up. The rate of intervention per 100 patient-years for nonfunctional adenomas was 3.1% (confidence interval 2.0-4.7%). All patients with nonfunctional adenoma who required an intervention reported symptoms or had an abnormal pituitary function test. Tumor volume of 38/48 (79%) nonfunctional adenomas followed over a mean of 8.3 ± 6.1 years remained stable. Only 42/518 (8.1%) MRIs for nonfunctional adenomas were prompted by clinical or biochemical abnormalities. Individualized imaging could have avoided approximately 4 MRIs per patient with nonfunctional microadenoma over their follow-up.

Conclusion

In an overwhelming majority of patients with MEN1, radiological surveillance for nonfunctional pituitary adenomas offers minimal added benefit beyond patient-reported symptoms and pituitary function testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pituitary NeoplasmsMultiple Endocrine Neoplasia Type 1AdenomaHumansMaleFemaleLongitudinal StudiesMagnetic Resonance ImagingRetrospective StudiesAdultMiddle AgedYoung AdultAdolescentFollow-Up StudiesCohort StudiesAged

Stichwörter der Autor:innen

heritable pituitary tumorsmeninneuroendocrine tumorspituitary screeningprolactinomastumor volumetrics

Autor:innen und Institutionen

  • Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20814, USA.
  • Office of the Director, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20814, USA.
  • National Institutes of Health Clinical Center, National Institutes of Health, Bethesda, MD 20814, USA.
  • Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC 27710, USA.
  • Neurosurgery Unit for Pituitary and Inheritable Diseases, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20814, USA.

ORCID-Profile: Prashant Chittiboina, William F Simonds, Smita Jha

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Omotosho, Y. B., Vikram, N. U., Wright, E. C., Dola, V., Abbas, W., Tora, R., Bliss, L., Cochran, C., Pieper, C. F., Chittiboina, P., Weinstein, L. S., Simonds, W. F., Biassou, N., & Jha, S. (2026). Radiological Surveillance for Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1: A Longitudinal Cohort Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf704

Vancouver

Omotosho YB, Vikram NU, Wright EC, Dola V, Abbas W, Tora R, et al. Radiological Surveillance for Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1: A Longitudinal Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgaf704

BibTeX
@article{Omotosho2026,
  author = {Omotosho, Yetunde B and Vikram, Nayan U and Wright, Elizabeth C and Dola, Venkata and Abbas, Wafa and Tora, Rana and Bliss, Lynn and Cochran, Craig and Pieper, Carl F and Chittiboina, Prashant and Weinstein, Lee S and Simonds, William F and Biassou, Nadia and Jha, Smita},
  title = {Radiological Surveillance for Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1: A Longitudinal Cohort Study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2026},
  doi = {10.1210/clinem/dgaf704}
}
Kostenlos starten →